| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1432810A4 Production of recombinant proteins in vivo and use for generating antibodies |
| 02/02/2005 | EP1266025A4 Protein scaffolds for antibody mimics and other binding proteins |
| 02/02/2005 | EP1141238B1 Production of proteins |
| 02/02/2005 | EP1135166B9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1572872A Method for the recombinant production of polypeptides |
| 02/02/2005 | CN1187618C Reagent box for fast detecting methyl amphetamine and its preparation process |
| 02/02/2005 | CN1187451C Method of making proteins in transformed yeast cells |
| 02/02/2005 | CN1187441C Medium for culturing animal cells and process for producing protein by using same |
| 02/02/2005 | CN1187373C Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition |
| 02/02/2005 | CN1187371C Method for preparing phycocyanin of sea water |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/01/2005 | US6849720 Monoclonal antibodies to the human LDL receptor, their production and use |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849419 Monoclonal antibody hybridoma immunoassay method and diagnosis kit |
| 02/01/2005 | US6849416 Immunoglobulin for use in diagnosis of nervous system and psychological disorders |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849405 Incorporated into expression vectors to enhance recombinant protein production |
| 02/01/2005 | US6849279 Glycoprotein; solvent extraction; prevention pollution, ultraviolet radiation damage |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 02/01/2005 | CA2248140C Assay and reagents for quantifying hbnp |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 02/01/2005 | CA2082605C Monitoring of nca-bt in blood samples of breast cancer patients |
| 01/27/2005 | WO2005007848A1 Process for producing l-histidine with the use of bacterium belonging to enterobacteriaceae |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007820A2 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 01/27/2005 | WO2005007808A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | WO2005007803A2 Selection free growth of host cells containing multiple integrating vectors |
| 01/27/2005 | WO2005007800A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 01/27/2005 | WO2005007698A1 Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody |
| 01/27/2005 | WO2005007697A1 Anti-influenza type a virus monoclonal antibody and immunoassay instrument using the antibody |
| 01/27/2005 | WO2005007674A2 Anti-human vitronectin antibody and methods for making the same |
| 01/27/2005 | WO2005007121A2 Mutant interleukin-2(il-2) polypeptides |
| 01/27/2005 | WO2004099424A3 Enrichment of enzymatic cleavage products |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003057826A3 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 01/27/2005 | US20050020522 Induce mitrosis and smooth muscle proliferation; administering to cell or tissue a polynucleotide which codes endothelial growth factor |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019864 Novel peptide-forming enzyme gene |
| 01/27/2005 | US20050019863 Culture product of Escherichia; transformation with plasmids using Dna sequences |
| 01/27/2005 | US20050019859 Mammalian ceII culture processes for protein production |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019857 Expression vector comprising outer membrane protein F (OMPF) regulatory and gene for use as tools in efficient heterologous gene expression; bioreactors |
| 01/27/2005 | US20050019855 Methods to increase the productivity of meterologous gene expression |
| 01/27/2005 | US20050019853 Production of heterologous polypeptides in yeast |
| 01/27/2005 | US20050019839 Secretions of proteins by encapsulated cells |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/27/2005 | US20050019331 Moderate neutrophilsin wound area; antiinflammatory agents; wound healing agents |
| 01/27/2005 | US20050019324 Peptides and antibodies to muc 1 proteins |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | CA2532781A1 The anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/27/2005 | CA2531695A1 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 01/27/2005 | CA2527878A1 Antibodies and fusion proteins that include engineered constant regions |
| 01/27/2005 | CA2525825A1 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499885A2 Novel fusion proteins and assays for molecular binding |
| 01/26/2005 | EP1499747A2 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 01/26/2005 | EP1499739A2 Methods for increasing homologous recombination of a nucleic acid sequence |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499725A1 Psp94 binding protein and psp94 diagnostic assays |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499723A2 Novel nucleic acids and polypeptides |
| 01/26/2005 | EP1499633A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 01/26/2005 | EP1499362A1 Fusions of cytokines and tumor targeting proteins |
| 01/26/2005 | EP1499354A2 Methods of using cytokine antagonists to treat hiv infection and aids |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |